Yakult Honsha : U.S.A. to Begin Considering the Construction of a New Production Facility
August 01, 2023 at 08:54 pm EDT
Share
Yakult U.S.A. to Begin Considering the Construction of a New
Production Facility
Signs MOU for Acquisition of Candidate Site for Production Facility
Yakult Honsha Co., Ltd. (President: Hiroshi Narita) today announced that its wholly owned subsidiary, Yakult U.S.A. Inc., signed a memorandum of understanding with Bartow County, Georgia, and Cartersville-Bartow County Department of Economic Development on July 18, 2023 (U.S. Eastern Time Zone) for the acquisition of a candidate site for building its second production facility in U.S.A.
The overview of the candidate site for the production facility and the profile of Yakult U.S.A. Inc. are as follows.
1. Location
Highland 75 Industrial Park, Bartow County, Georgia
2. Profile of Yakult U.S.A. Inc.
Name: Yakult U.S.A. Inc.
Established: October 1990
Capitalization: 152.6 million U.S. dollars (as of the end of December 2022) (wholly owned by Yakult Honsha Co., Ltd.)
Location: Fountain Valley, Orange County, California
Representative: Yutaka Misumi
Employees: 155 (as of the end of March 2023)
Sales: 632,000 bottles per day (results from January to December 2022)
Attachments
Original Link
Original Document
Permalink
Disclaimer
Yakult Honsha Co. Ltd. published this content on 02 August 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 August 2023 00:53:08 UTC.
YAKULT HONSHA CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of dairy products and pharmaceuticals. The Company operates in three business segments. The Beverages and Food Manufacturing and Sale segment is engaged in the manufacture and sale of dairy products, beverages, noodles and healthy food, the purchase and sale of materials, as well as the transportation business. The Company operates business in Japan, the Americas, Europe, Asia and Oceania. The Pharmaceuticals Manufacturing and Sale segment is engaged in the manufacture and sale of anticancer drugs and other ethical drugs. The Others segment is engaged in the production and sale of cosmetics, as well as the operation of professional baseball clubs.